S-Space

Browse

Author

Jump to a point in the index

Or type in a year

Sort by
In order
Results/Page
Authors/record

Showing results 1 to 60 of 391

Issue Date	Title / Author(s) / Citation	File
1999-10	Phase II clinical trial of SKI-2053R, a new platinum analog, in the treatment of patients with advanced gastric adenocarcinoma Kim, Noe Kyeong; Im, Seock-Ah; Kim, Dong-Wam; Lee, Moon H.; Jung, Chul W.; Cho, Eun K.; Lee, Jong T.; Ahn, Jin S.; Heo, Dae S.; Bang, Yung-Jue Cancer, Vol.86 No.7, pp.1109-1115	DOI
2002-07	Colorectal cancer in Korea: characteristics and trends Kim, Dong-Wan; Bang, Yung-Jue; Heo, Dae Seog; Kim, Noe Kyeong Tumori, Vol.88 No.4, pp.262-265	DOI
2003-12	Doxorubicin-based chemotherapy for diffuse large B-cell lymphoma in elderly patients - Comparison of treatment outcomes between young and elderly patients and the significance of doxorubicin dosage Lee, Keun-Wook; Kim, Dae-Young; Yun, Tak; Kim, Dong-Wan; Kim, Tae-You; Yoon, Sung-Soo; Heo, Dae Seog; Bang, Yung-Jue; Park, Seonyang; Kim, Byoung Kook; Kim, Noe Kyeong Cancer, Vol.98 No.12, pp.2651-2656	DOI
2003-12	Comparison of intrathecal chemotherapy for leptomeningeal carcinomatosis of a solid tumor: Methotrexate alone versus methotrexate in combination with cytosine arabinoside and hydrocortisone Kim, Dae-Young; Lee, Keun-Wook; Yun, Tak; Park, Sook Ryun; Jung, Joo Young; Kim, Dong-Wan; Kim, Tae-You; Heo, Dae Seog; Bang, Yung-Jue; Kim, Noe Kyeong Japanese Journal of Clinical Oncology, Vol.33 No.12, pp.608-612	DOI
2004-06	Elevated TGF-β1 Secretion and Down-Modulation of NKG2D Underlies Impaired NK Cytotoxicity in Cancer Patients Lee, June-Chul; Lee, Kyung-Mi; Kim, Dong-Wan; Heo, Dae Seog Journal of Immunology, Vol.172 No.12, pp.7335-7340	DOI
2004-06	Phase I and pharmacokinetic study of Genexol-PM, a cremophor-free, polymeric micelle-formulated paclitaxel, in patients with advanced malignancies Kim, Tae You; Kim, Dong-Wan; Chung, Jae-Yong; Shin, Sang Goo; Kim, Sung-Chul; Heo, Dae Seog; Kim, Noe Kyeong; Bang, Yung-Jue Clinical Cancer Research, Vol.10 No.11, pp.3708-3716	DOI
2004-07	Single-agent capecitabine in patients with metastatic colorectal cancer refractory to 5-fluorouracil/leucovorin chemotherapy Lee, Jae Jin; Kim, Tae Min; Yu, Su Jong; Kim, Dong-Wan; Joh, Yo-han; Oh, Do-Youn; Kwon, Jung Hye; Kim, Tae-You; Heo, Dae Seog; Bang, Yung-Jue; Kim, Noe Kyeong Japanese Journal of Clinical Oncology, Vol.34 No.7, pp.400-404	DOI
2004-11	Neoadjuvant etoposide, ifosfamide, and cisplatin for the treatment of olfactory neuroblastoma Kim, Dong-Wan; Jo, Yo-Han; Kim, Jee Hyun; Wu, Hong-Gyun; Rhee, Chae Seo; Lee, Chol Hee; Kim, Tae You; Heo, Dae Seog; Bang, Yung-Jue; Kim, Noe Kyeong Cancer, Vol.101 No.10, pp.2257-2260	DOI
2004-11	A multi-center, late phase II clinical trial of Genexol (R) (paclitaxel) and cisplatin for patients with advanced gastric cancer Park, Sook Ryun; Oh, Do Youn; Kim, Dong Wan; Kim, Tae You; Heo, Dae Seog; Bang, Yung-Jue; Kim, Noe Kyeong; Kang, Won Ki; Kim, Heung-Tae; Im, Seock Ah; Suh, Jae-Hong; Kim, Hark-Kyun; Kim, Hoon-Kyo Oncology Reports, Vol.12 No.5, pp.1059-1064	DOI
2005-01	Paclitaxel/platinum-based perioperative chemotherapy and surgery in stage IIIA non-small cell lung cancer Choi, In Sil; Oh, Do-Youn; Kwon, Jung Hye; Kim, Sang-Il; Park, Sook Ryun; Bak, Ji-Youn; Kim, Jee Hyun; Kim, Dong-Wan; Kim, Young Tae; Kim, Tae You; You, Chul-Kyu; Kim, Young Whan; Heo, Dae Seog; Bang, Yung-Jue; Sung, Sook Whan; Park, Charn Il; Kim, Noe Kyeong Japanese Journal of Clinical Oncology, Vol.35 No.1, pp.6-12	DOI
2005-01	Epidermal growth factor receptor (EGFR) downstream molecules as response predictive markers for gefitinib (Iressa (R), ZD1839) in chemotherapy-resistant non-small cell lung cancer Han, Sae-Won; Hwang, Pil Gyu; Chung, Doo Hyun; Kim, Dong-Wan; Im, Seock-Ah; Kim, Young Tae; Kim, Tae-You; Heo, Dae Seog; Bang, Yung-Jue; Kim, Noe Kyeong International Journal of Cancer, Vol.113 No.1, pp.109-115	DOI
2005-04	Predictive and prognostic impact of epidermal growth factor receptor mutation in non-small-cell lung cancer patients treated with gefitinib Han, Sae-Won; Kim, Tae-You; Hwang, Pil Gyu; Jeong, Soohyun; Kim, Jeongmi; Choi, In Sil; Oh, Do Youn; Kim, Jee Hyun; Kim, Dong-Wan; Chung, Doo Hyun; Im, Seock-Ah; Kim, Young Tae; Lee, Jong Seok; Heo, Dae Seog; Bang, Yung-Jue; Kim, Noe Kyeong Journal of Clinical Oncology, Vol.23 No.11, pp.2493-2501	DOI
2005-07	Docetaxel+5-fluorouracil plus cisplatin 3-day combination chemotherapy as a first-line treatment in patient with unresectable gastric cancer Oh, Do-Youn; Kim, Tae-Yong; Kwon, Jung Hye; Lee, Jae-Jin; Joh, Yohan; Kim, Dong-Wan; Kim, Tae-You; Heo, Dae Seog; Bang, Yung-Jue; Kim, Noe Kyeong Japanese Journal of Clinical Oncology, Vol.35 No.7, pp.380-385	DOI
2005-07	Efficacy of platinum-based chemotherapy after cranial radiation in patients with brain metastasis from non-small cell lung cancer Kim, Dae-Young; Lee, Keun-Wook; Yun, Tak; Kim, Dong-Wan; Kim, Tae-You; Heo, Dae Seog; Bang, Yung-Jue; Kim, Noe Kyeong Oncology Reports, Vol.14 No.1, pp.207-211	DOI
2005-10	Reduced dose intensity FOLFOX-4 as first line palliative chemotherapy in elderly patients with advanced colorectal cancer Kim, Jee Hyun; Oh, Do Youn; Kim, Yu Jung; Han, Sae Won; Choi, In-Sil; Kim, Dong Wan; Im, Seock Ah; Kim, Tae You; Lee, Jong Seok; Heo, Dae Seog; Bang, Yung-Jue; Kim, Noe Kyeong Journal of Korean Medical Science, Vol.20 No.5, pp.806-810	DOI
2005-12	Local tumor invasiveness is more predictive of survival than International Prognostic Index in stage I-E/IIE extranodal NK/T-cell lymphoma, nasal type Kim, Tae Min; Park, Yeon Hee; Lee, Sang-Yoon; Kim, Ji-Hoon; Kim, Dong-Wan; Im, Seock-Ah; Kim, Tae-You; Kim, Chul Woo; Heo, Dae Seog; Bang, Yung-Jue; Chang, Kee-Hyun; Kim, Noe Kyeong Blood, Vol.106 No.12, pp.3785-3790	DOI
2005-12	Phase II trial of low-dose paclitaxel and cisplatin in patients with advanced gastric cancer Lee, Keun-Wook; Im, Seock Ah; Yun, Tak; Song, Eun Kee; Na, Im Il; Shin, Hyunchoon; Choi, In Sil; Oh, Do Youn; Kim, Jee Hyun; Kim, Dong Wan; Kim, Tae You; Lee, Jong Seok; Heo, Dae Seog; Bang, Yung-Jue; Kim, Noe Kyeong Japanese Journal of Clinical Oncology, Vol.35 No.12, pp.720-726	DOI
2006-02	CPR or DNR? End-of-life decision in Korean cancer patients: a single center's experience Oh, Do-Youn; Kim, Jee-Hyun; Kim, Dong-Wan; Im, Seock-Ah; Kim, Tae You; Heo, Dae Seog; Bang, Yung-Jue; Kim, Noe Kyeong Supportive Care in Cancer, Vol.14 No.2, pp.103-108	DOI
2006-03	Antibiotic use during the last days of life in cancer patients Oh, D. Y.; Kim, J. H.; Kim, D. W.; Im, S. A.; Kim, T. Y.; Heo, D. S.; Bang, Y. J.; Kim, N. K. European Journal of Cancer Care, Vol.15 No.1, pp.74-79	DOI
2006-04	Optimization of patient selection for gefitinib in non-small cell lung cancer by combined analysis of epidermal growth factor receptor mutation, K-ras mutation, and Akt phosphorylation Han, Sae-Won; Kim, Tae-You; Jeon, Young Kyung; Hwang, Pil Gyu; Im, Seock-Ah; Lee, Kyung-Hun; Kim, Jee Hyun; Kim, Dong-Wan; Heo, Dae-Seog; Kim, Noe Kyeong; Chung, Doo Hyun; Bang, Yung-Jue Clinical Cancer Research, Vol.12 No.8, pp.2538-2544	DOI
2006-06	Epidermal growth factor receptor mutations and response to chemotherapy in patients with non-small-cell lung cancer Lee, Kyung-Hun; Han, Sae-Won; Hwang, Pil Gyu; Oh, Do-Youn; Kim, Dong-Wan; Chung, Doo Hyun; Im, Seock-Ah; Kim, Tae-You; Heo, Dae Seog; Bang, Yung-Jue Japanese Journal of Clinical Oncology, Vol.36 No.6, pp.344-350	DOI
2006-07	First-line ifosfamide, methotrexate, etoposide and prednisolone chemotherapy +/- radiotherapy is active in stage I/II extranodal NK/T-cell lymphoma Lee, Keun-Wook; Yun, Tak; Kim, Dong-Wan; Im, Seock-Ah; Kim, Tae-You; Yoon, Sung-Soo; Heo, Dae Seog; Bang, Yung-Jue; Park, Seonyang; Kim, Byoung Kook; Kim, Noe Kyeong Leukemia and Lymphoma, Vol.47 No.7, pp.1274-1282	DOI
2006-07	High fluorodeoxyglucose uptake on positron emission tomography in patients with advanced non-small cell lung cancer on platinum-based combination chemotherapy Lee, Kyung-Hun; Lee, Se-Hoon; Kim, Dong-Wan; Kang, Won Jun; Chung, June-Key; Im, Seock-Ah; Kim, Tae-You; Kim, Young Whan; Bang, Yung-Jue; Heo, Dae Seog Clinical Cancer Research, Vol.12 No.14, pp.4232-4236	DOI
2006-08	Primary systemic anaplastic large cell lymphoma in a single Korean institution: Clinical characteristics and treatment outcome Park, Sook Ryun; Baek, Ji Yeon; Kim, Dong-Wan; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue; Kim, Noe Kyeong; Jeon, Yoon Kyung; Kim, Chul Woo; Heo, Dae Seog Journal of Korean Medical Science, Vol.21 No.4, pp.633-638	view file DOI
2006-11	Clinical predictors versus epidermal growth factor receptor mutation in gefitinib-treated non-small-cell lung cancer patients Han, Sae-Won; Kim, Tae-You; Lee, Kyung-Hun; Hwang, Pil Gyu; Jeon, Yoon Kyung; Oh, Do-Youn; Lee, Se-Hoon; Kim, Dong-Wan; Im, Seock-Ah; Chung, Doo Hyun; Heo, Dae Seog; Bang, Yung-Jue Lung Cancer, Vol.54 No.2, pp.201-207	DOI
2007-04	Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy Lee, Kyung-Hun; Im, Seock-Ah; Oh, Do-Youn; Lee, Se-Hoon; Chie, Eui Kyu; Han, Wonshik; Kim, Dong-Wan; Kim, Tae-You; Park, In Ae; Noh, Dong-Young; Heo, Dae Seog; Ha, Sung Whan; Bang, Yung-Jue BMC Cancer, Vol.7, p. 63	view file DOI
2007-05	Intron 1 CA dinucleotide repeat polymorphism and mutations of epidermal growth factor receptor and gefitinib responsiveness in non-small-cell lung cancer Han, Sae-Won; Jeon, Yoon Kyung; Lee, Kyung-Hun; Keam, Bhumsuk; Hwang, Pil Gyu; Oh, Do-Youn; Lee, Se-Hoon; Kim, Dong-Wan; Im, Seock-Ah; Chung, Doo Hyun; Heo, Dae Seog; Bang, Yung-Jue; Kim, Tae-You Pharmacogenetics and Genomics, Vol.17 No.5, pp.313-319	DOI
2007-06	Artificial nutrition and hydration in terminal cancer patients: the real and the ideal Oh, Do Youn; Kim, Jee Hyun; Lee, Se Hoon; Kim, Dong Wan; Im, Seock-Ah; Kim, Tae You; Heo, Dae Seog; Bang, Yung Jue; Kim, Noe Kyeong Supportive Care in Cancer, Vol.15 No.6, pp.631-636	DOI
2007-09	Phase II study of low-dose paclitaxel and cisplatin as a second-line therapy after 5-fluorouracil/platinum chemotherapy in gastric cancer Lee, Keun-Wook; Kim, Jee Hyun; Yun, Tak; Song, Eun Kee; Na, Im Il; Shin, Hytinchoon; Oh, So Yeon; Choi, In Sil; Oh, Do-Youn; Kim, Dong-Wan; Im, Seock-Ah; Kim, Tae-You; Lee, Jong Seok; Heo, Dae Seog; Bang, Yung-Jue; Kim, Noe Kyeong Journal of Korean Medical Science, Vol.22, pp.S115-S121	view file
2007-10	Palliative chemotherapy for pulmonary pleomorphic carcinoma Bae, Hyun-Mi; Min, Hye Sook; Lee, Se-Hoon; Kim, Dong-Wan; Chung, Doo Hyun; Lee, Jong-Seok; Kim, Young Whan; Heo, Dae Seog Lung Cancer, Vol.58 No.1, pp.112-115	DOI
2007-11	Prognostic impact of clinicopathologic parameters in stage II/III breast cancer treated with neoadjuvant docetaxel and doxorubicin chemotherapy: paradoxical features of the triple negative breast cancer Keam, Bhumsuk; Im, Seock-Ah; Kim, Hee-Jun; Oh, Do-Youn; Kim, Jee Hyun; Lee, Se-Hoon; Chie, Eui Kyu; Han, Wonshik; Kim, Dong-Wan; Moon, Woo Kyung; Kim, Tae-You; Park, In Ae; Noh, Dong-Young; Heo, Dae Seog; Ha, Sung Whan; Bang, Yung-Jue BMC Cancer, Vol.7, p. 203	view file DOI
2007-12	Multicenter phase II trial of Genexol-PM, a novel Cremophor-free, polymeric micelle formulation of paclitaxel, with cisplatin in patients with advanced non-small-cell lung cancer Kim, D. -W.; Kim, S. -Y.; Kim, H. -K.; Kim, S. -W.; Shin, S. W.; Kim, J. S.; Park, K.; Lee, M. Y.; Heo, D. S. Annals of Oncology, Vol.18 No.12, pp.2009-2014	DOI
2008-01	A phase II trial of S-1 and cisplatin in patients with metastatic or relapsed biliary tract cancer Kim, Y. J.; Im, S. -A.; Kim, H. G.; Oh, S. Y.; Lee, K. W.; Choi, I. S.; Oh, D. Y.; Lee, S. H.; Kim, J. H.; Kim, D. W.; Kim, T. Y.; Kim, S. W.; Heo, D. S.; Yoon, Y. B.; Bang, Y. J. Annals of Oncology, Vol.19 No.1, pp.99-103	DOI
2008-02	Efficacy of chemotherapy as a first-line treatment in ocular adnexal extranodal marginal zone B-cell lymphoma Song, E. -K.; Kim, S. -Y.; Kim, T. M.; Lee, K. -W.; Yun, T.; Na, I. -I.; Shin, H.; Lee, S. H.; Kim, D. W.; Khwarg, S. I.; Heo, D. S. Annals of Oncology, Vol.19 No.2, pp.242-246	DOI
2008-02	Metastasis-associated protein S100A4 and p53 predict relapse in curatively resected stage III and IV (M0) gastric cancer Kim, Yu Jung; Kim, Min A.; Im, Seock-Ah; Kim, Tae Min; Kim, Dong-Wan; Yang, Han-Kwang; Heo, Dae Seog; Lee, Kuhn-Uk; Choe, Kuk Jin; Kim, Noe Kyeong; Kim, Tae-You; Kim, Woo Ho; Bang, Yung-Jue Cancer Investigation, Vol.26 No.2, pp.152-158	DOI
2008-03	Long-term survival of resectable subset after induction chemotherapy in patients with locally advanced head and neck cancer Cho, Yo-Han; Lee, Se Hoon; Kim, Dong-Wan; Wu, Hong-Gyun; Hah, J. Hun; Rhee, Chae-Seo; Sung, Myung-Whun; Kim, Kwang Hyun; Heo, Dae Soeg Head and Neck, Vol.30 No.3, pp.346-350	DOI
2008-03	High tumour islet macrophage infiltration correlates with improved patient survival but not with EGFR mutations, gene copy number or protein expression in resected non-small cell lung cancer Kim, D-W; Min, H. S.; Lee, K-H; Kim, Y. J.; Oh, D-Y; Jeon, Y. K.; Lee, S. -H.; Im, S. -A.; Chung, D. H.; Kim, Y. T.; Kim, T. -Y.; Bang, Y. -J.; Sung, S. W.; Kim, J. H.; Heo, D. S. British Journal of Cancer, Vol.98 No.6, pp.1118-1124	DOI
2008-05	Aggressiveness of cancer-care near the end-of-life in Korea Keam, Bhumsuk; Oh, Do-Youn; Lee, Se-Hoon; Kim, Dong-Wan; Kim, Mi Ra; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue; Heo, Dae Seog Japanese Journal of Clinical Oncology, Vol.38 No.5, pp.381-386	DOI
2008-05	A Phase II study of 5-fluorouracil and cisplatin systemic chemotherapy for inoperable hepatocellular carcinoma with α fetoprotein as a predictive and prognostic marker Keam, Bhumsuk; Oh, Do-Youn; Lee, Se-Hoon; Kim, Dong-Wan; Im, Seock-Ah; Kim, Tae-You; Heo, Dae Seog; Bang, Yung-Jue Molecular Medicine Reports, Vol.1 No.3, pp.415-422	DOI
2008-05	Modified FOLFOX-6 chemotherapy in advanced gastric cancer: Results of phase II study and comprehensive analysis of polymorphisms as a predictive and prognostic marker Keam, Bhumsuk; Im, Seock-Ah; Han, Sae-Won; Ham, Hye Seon; Kim, Min A.; Oh, Do-Youn; Lee, Se-Hoon; Kim, Jee Hyun; Kim, Dong-Wan; Kim, Tae-You; Heo, Dae Seog; Kim, Woo Ho; Bang, Yung-Jue BMC Cancer, Vol.8, p. 148	view file DOI
2008-06	Gemcitabine and Vinorelbine Combination Chemotherapy in Anthracycline- and Taxane-pretreated Advanced Breast Cancer Kim, Hye Jin; Kim, Jin-Soo; Seo, Myung-Deok; Oh, So-Yeon; Oh, Do Youn; Kim, Jee Hyun; 이세훈; Kim, Dong Wan; Im, Seock Ah; Kim, Tae You; Heo, Dae Seog; Bang, Yung-Jue Cancer Research and Treatment, Vol.40 No.2, pp.81-86
2008-06	ERCC1 expression by immunohistochemistry and EGFR mutations in resected non-small cell lung cancer Lee, Kyung-Hun; Min, Hye Sook; Han, Sae-Won; Oh, Do-Youn; Lee, Se-Hoon; Kim, Dong-Wan; Im, Seock-Ah; Chung, Doo Hyun; Kim, Young Tae; Kim, Tae-You; Heo, Dae Seog; Bang, Yung-Jue; Sung, Sook Whan; Kim, Joo Hyun Lung Cancer, Vol.60 No.3, pp.401-407	DOI
2008-07	Mucoepidermoid carcinoma of lung: Potential target of EGFR-directed treatment Han, Sae-Won; Kim, Hwang-Phill; Jeon, Yoon Kyung; Oh, Do-Youn; Lee, Se-Hoon; Kim, Dong-Wan; Im, Seock-Ah; Chung, Doo Hyun; Heo, Dae Seog; Bang, Yung-Jue; Kim, Tae-You Lung Cancer, Vol.61 No.1, pp.30-34	DOI
2008-11	Cancer patients' awareness of clinical trials, perceptions on the benefit and willingness to participate: Korean perspectives Kim, J. W.; Kim, S. -J.; Chung, Y. -H.; Kwon, J. -H.; Lee, H. -J.; Chung, Y. -J.; Kim, Y. J.; Oh, Do-Youn; Lee, S. -H.; Kim, D. -W.; Im, S. -A.; Kim, T. -Y.; Heo, D. S.; Bang, Y. -J. British Journal of Cancer, Vol.99 No.10, pp.1593-1599	DOI
2008-12	Risk factors for bacterial pneumonia after cytotoxic chemotherapy in advanced lung cancer patients Lee, Jeong-Ok; Kim, Dae-Young; Lim, Joo Han; Seo, Myung-Deock; Yi, Hyeon Gyu; Kim, Yu Jung; Lee, Se-Hoon; Kim, Dong-Wan; Yang, Seok-Chul; Kim, Young Whan; Heo, Dae Seog Lung Cancer, Vol.62 No.3, pp.381-384	DOI
2008-12	Gemcitabine-based versus fluoropyrimidine-based chemotherapy with or without platinum in unresectable biliary tract cancer: a retrospective study Kim, Mi-Jung; Oh, Do-Youn; Lee, Se-Hoon; Kim, Dong-Wan; Im, Seock-Ah; Kim, Tae-You; Heo, Dae Seog; Bang, Yung-Jue BMC Cancer, Vol.8, p. 374	view file DOI
2009-01	Effective second-line chemotherapy for extranodal NK/T-cell lymphoma consisting of etoposide, ifosfamide, methotrexate, and prednisolone Kim, B. -S.; Kim, D. -W.; Im, S. -A.; Kim, C. W.; Kim, T. -Y.; Yoon, S. -S.; Heo, D. S.; Bang, Y. -J.; Park, S.; Kim, B. K.; Kim, N. K. Annals of Oncology, Vol.20 No.1, pp.121-128	DOI
2009-03	Biomarker analysis in stage III-IV (M0) gastric cancer patients who received curative surgery followed by adjuvant 5-fluorouracil and cisplatin chemotherapy: epidermal growth factor receptor (EGFR) associated with favourable survival Kim, J. -S.; Kim, M. -A.; Kim, T. M.; Lee, S. -H.; Kim, D. -W.; Im, S. -A.; Kim, T. -Y.; Kim, W. H.; Yang, H. -K.; Heo, D. S.; Bang, Y. -J.; Lee, K. -U.; Choe, K. -J.; Kim, N. K. British Journal of Cancer, Vol.100 No.5, pp.732-738	DOI
2009-03	The role of PET/CT in detection of gastric cancer recurrence Sim, Sung Hoon; Kim, Yu Jung; Oh, Do-Youn; Lee, Se-Hoon; Kim, Dong-Wan; Kang, Won Jun; Im, Seock-Ah; Kim, Tae-You; Kim, Woo Ho; Heo, Dae Seog; Bang, Yung-Jue BMC Cancer, Vol.9, p. 73	view file DOI
2009-05	Preradiation chemotherapy with ACNU-CDDP in patients with newly diagnosed glioblastoma: A retrospective analysis Han, Jung Ho; Park, Chul-Kee; Lee, Se-Hoon; Kim, Chae-Yong; Kim, Dong-Wan; Paek, Sun Ha; Kim, Dong Gyu; Heo, Dae Seog; Kim, Il Han; Jung, Hee-Won Chemotherapy, Vol.55 No.3, pp.145-154	view file DOI
2009-07	Clinical significance of axillary nodal ratio in stage II/III breast cancer treated with neoadjuvant chemotherapy Keam, Bhumsuk; Im, Seock-Ah; Kim, Hee-Jun; Oh, Do-Youn; Kim, Jee Hyun; Lee, Se-Hoon; Chie, Eui Kyu; Han, Wonshik; Kim, Dong-Wan; Cho, Nariya; Moon, Woo Kyung; Kim, Tae-You; Park, In Ae; Noh, Dong-Young; Heo, Dae Seog; Ha, Sung Whan; Bang, Yung-Jue Breast Cancer Research and Treatment, Vol.116 No.1, pp.153-160	DOI
2009-07	Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) are effective for leptomeningeal metastasis from non-small cell lung cancer patients with sensitive EGFR mutation or other predictive factors of good response for EGFR TKI Yi, Hyeon Gyu; Kim, Hye Jin; Kim, Yu Jung; Han, Sae-Won; Oh, Do-Youn; Lee, Se-Hoon; Kim, Dong-Wan; Im, Seock-Ah; Kim, Tae-You; Kim, Chul Soo; Heo, Dae Seog; Bang, Yung-Jue Lung Cancer, Vol.65 No.1, pp.80-84	DOI
2009-08	Methylation status of the MGMT gene promoter fails to predict the clinical outcome of glioblastoma patients treated with ACNU plus cisplatin Park, Chul-Kee; Park, Sung-Hye; Lee, Se-Hoon; Kim, Chae-Yong; Kim, Dong-Wan; Paek, Sun Ha; Kim, Dong Gyu; Heo, Dae Seog; Kim, Il Han; Jung, Hee-Won Neuropathology, Vol.29 No.4, pp.443-449	DOI
2009-08	Class III beta-tubulin, but not ERCC1, is a strong predictive and prognostic marker in locally advanced head and neck squamous cell carcinoma Koh, Y.; Kim, T. M.; Jeon, Y. K.; Kwon, T. -K.; Hah, J. H.; Lee, S. -H.; Kim, D. -W.; Wu, H. -G.; Rhee, C. -S.; Sung, M. -W.; Kim, C. W.; Kim, K. H.; Heo, D. S. Annals of Oncology, Vol.20 No.8, pp.1414-1419	DOI
2009-08	Patterns of palliative procedures and clinical outcomes in patients with advanced non-small cell lung cancer Kim, Hee Jun; Kim, Yu Jung; Seo, Myung-Deok; Yi, Hyeon Gyu; Lee, Se-Hoon; Lee, Sang-Min; Kim, Dong-Wan; Yang, Seok-Chul; Lee, Choon-Taek; Lee, Jong Seok; Kim, Young-Whan; Heo, Dae Seog Lung Cancer, Vol.65 No.2, pp.242-246	DOI
2009-08	Erlotinib after Gefitinib failure in female never-smoker Asian patients with pulmonary adenocarcinoma Sim, Sung Hoon; Han, Sae-Won; Oh, Do-Youn; Lee, Se-Hoon; Kim, Dong-Wan; Im, Seock-Ah; Chung, Doo Hyun; Kim, Tae-You; Lee, Jong Seok; Kim, Young Whan; Heo, Dae Seog; Bang, Yung-Jue Lung Cancer, Vol.65 No.2, pp.204-207	DOI
2009-09	Risk factors for poor treatment outcome and central nervous system relapse in diffuse large B-cell lymphoma with bone marrow involvement Lee, Keun-Wook; Yi, Jongyoun; Choi, In Sil; Kim, Jee Hyun; Bang, Soo-Mee; Kim, Dong-Wan; Im, Seock-Ah; Kim, Tae-You; Yoon, Sung-Soo; Lee, Jong Seok; Bang, Yung-Jue; Park, Seonyang; Kim, Byoung Kook; Cho, Han Ik; Heo, Dae Seog Annals of Hematology, Vol.88 No.9, pp.829-838	DOI
2009-10	Increased quantity of tumor-infiltrating FOXP3-positive regulatory T cells is an independent predictor for improved clinical outcome in extranodal NK/T-cell lymphoma Kim, W. Y.; Jeon, Y. K.; Kim, T. M.; Kim, J. E.; Kim, Y. A.; Lee, S. -H.; Kim, D. -W.; Heo, D. S.; Kim, C. -W. Annals of Oncology, Vol.20 No.10, pp.1688-1696	DOI
2009-11	Differences in the Expression Profiles of Excision Repair Crosscomplementation Group 1, X-Ray Repair Crosscomplementation Group 1, and beta III-Tubulin Between Primary Non-small Cell Lung Cancer and Metastatic Lymph Nodes and the Significance in Mid-Term Survival Kang, Chang Hyun; Jang, Bo Gun; Kim, Dong-Wan; Chung, Doo Hyun; Kim, Young Tae; Jheon, Sanghoon; Sung, Sook-Whan; Kim, Joo Hyun Journal of Thoracic Oncology, Vol.4 No.11, pp.1307-1312	DOI
2009-12	Recursive partitioning analysis of prognostic factors in WHO grade III glioma patients treated with radiotherapy or radiotherapy plus chemotherapy Park, Chul-Kee; Lee, Se-Hoon; Han, Jung Ho; Kim, Chae-Yong; Kim, Dong-Wan; Paek, Sun Ha; Kim, Dong Gyu; Heo, Dae Seog; Kim, Il Han; Jung, Hee-Won BMC Cancer, Vol.9, p. 450	view file DOI

1 2 3 4 5 6 7